NATIONAL WESTERN LIFE GROUP, INC. (NASDAQ:NWLI) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On August 18, 2017, the Class B Directors of National Western Life Group, Inc. (the “Company”) elected Dr. Thomas A. Blackwell a Class B Director of the Company to serve until the 2018 Annual Meeting of Stockholders. Dr. Blackwell fills the vacancy created by the resignation of Louis E. Pauls, Jr. effective August 17, 2017. The Company’s Restated Certificate of Incorporation and Amended and Restated Bylaws provide that in the event of a vacancy on the Company’s Board of Directors (the "Board") the vacancy be filled by a vote of a majority of the remaining elected directors in the class whose position is being filled.
Dr. Blackwell is the Associate Dean for Graduate Medical Education and Professor of Medicine at the University of Texas Medical Branch in Galveston.
There are no arrangements or understandings between Dr. Blackwell and any other persons to which Dr. Blackwell was elected and there have been no related party transactions between Dr. Blackwell and the Company that would be reportable under Item 404(a) of Regulation S-K. The Board of Directors has determined that Dr. Blackwell is “independent” under the Company’s corporate governance guidelines and The NASDAQ Stock Market listing standards and has appointed Dr. Blackwell to the Audit Committee and the Compensation Committee.
As a nonemployee director of the Company, Dr. Blackwell will receive the same compensation as the other nonemployee members of the Board as described in the Company’s Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission, most recently April 28, 2017, with the annual retainer fee prorated for 2017.